Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Deutsche Boerse AG  >  GlaxoSmithKline plc    GS7   GB0009252882

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo GlaxoSmithKline plc
Develops, manufactures and distributes vaccines and other pharmaceutical products

GlaxoSmithKline Plc operates as a science-led global healthcare company that researches and develops a broad range of innovative medicines and brands.

It operates in three primary areas of business: Pharmaceuticals, Vaccines and Consumer Healthcare.

The Pharmaceuticals business researches, develops and makes available medicines that treat a variety of serious and chronic diseases.

The Vaccines business produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza and bacterial meningitis.

The Consumer Healthcare business markets a range of consumer health products based on scientific innovation.

The company was founded on December 6, 1999 and is headquartered in Brentford, United Kingdom.
Managers
NameAgeSinceTitle
Emma Walmsley-2010Chief Executive Officer & Executive Director
Philip Hampton532015Non-Executive Chairman
Simon Dingemans532011Chief Financial Officer & Executive Director
Birgitte Volck MD, PhD552016Head-Research & Development
Moncef Slaoui, PhD562006Executive Director & Chairman-Global Vaccines
Roy Malcolm Anderson692007Independent Non-Executive Director
Patrick J. T. Vallance, MD-2006Executive Director
Judy Carol Lewent682011Independent Non-Executive Director
Lynn Laverty Elsenhans, MBA602012Independent Non-Executive Director
Urs Rohner582015Independent Non-Executive Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 5,375,505,886 4,857,316,891 90.4% 458,205,950 8.5% 90.4%
Shareholders
NameEquities%
BlackRock Investment Management (UK) Ltd. 207,257,650 4.22%
Legal & General Investment Management Ltd. 147,931,457 3.01%
The Vanguard Group, Inc. 126,462,172 2.57%
Norges Bank Investment Management 95,420,000 1.94%
BlackRock Advisors (UK) Ltd. 88,133,021 1.79%
Capital Research & Management Co. (Global Investors) 84,447,744 1.72%
Woodford Investment Management LLP 68,942,322 1.40%
State Street Global Advisors Ltd. 63,826,932 1.30%
Threadneedle Asset Management Ltd. 58,478,191 1.19%
Woodford Investment Management Ltd. 57,224,173 1.16%
Holdings
NameEquities%Valuation
Innoviva Inc (INVA) 32,005,26029.3%442,632,746 USD
Theravance Biopharma Inc (TBPH) 9,644,80718.2%355,121,794 USD
JCR Pharmaceuticals Co Ltd (4552) 7,986,00024.6%176,949,076 USD
Crispr Therapeutics AG (CRSP) 3,220,6278.09%70,113,050 USD
Dong-A Socio Holdings Co Ltd (000640) 409,6936.67%48,358,650 USD
GlaxoSmithKline S.A.E. 76,161,37891.2%48,242,902 USD
Oncomed Pharmaceuticals Inc (OMED) 2,607,5466.97%24,015,499 USD
Glaxo Smithkline Consumer Nig PLC (GLAXOSM) 444,065,54137.1%20,311,558 USD
Allergy Therapeutics plc (AGY) 10,118,0001.70%3,447,709 USD
SCYNEXIS Inc (SCYX) 545,0062.14%1,504,217 USD
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
Advertisement
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
GLAXOSMITHKLINE PLC3.07%99 096
JOHNSON & JOHNSON7.20%334 822
ROCHE HOLDING LTD.10.83%223 653
PFIZER INC.3.94%201 581
NOVARTIS AG2.77%201 384
MERCK & CO., INC.6.51%171 894
SANOFI11.38%120 619
GLAXOSMITHKLINE PLC0.26%99 096
BAYER AG9.00%97 392
ELI LILLY AND CO10.40%89 328
BRISTOL-MYERS SQUIBB C..-7.99%88 586
ALLERGAN PLC14.04%80 351
ASTRAZENECA PLC5.61%76 157
ABBOTT LABORATORIES14.03%75 686
NOVO NORDISK A/S0.67%73 753
SHIRE PLC-1.77%53 584
TAKEDA PHARMACEUTICAL ..10.18%37 821
TEVA PHARMACEUTICAL IN..-18.73%31 699
ASTELLAS PHARMA INC-6.77%30 296
MYLAN NV-1.86%20 049
CHUGAI PHARMACEUTICAL ..17.73%19 850
Sector Pharmaceuticals - NEC
GlaxoSmithKline plc : Connections
Opernhaus Zürich AG
Central Houston, Inc.
PhRMA Foundation
Biotechnology Innovation Organization
Longwood Fund Management LLC
Credit Suisse Americas Foundation
The Natural History Museum
Economiesuisse
Institute of Medicine
World Golf Foundation, Inc.
French Academy of Sciences
TFS Trial Form Support AB
Pearson Education Ltd.
The Institute of International Finance, Inc.
Genome Research Ltd.
Alfred Escher-Stiftung
Office for Strategic Co-ordination of Health Research
International AIDS Vaccine Initiative, Inc.
The 100 Group
Rice University
The Council for Industry & Higher Education
The Texas Medical Center
Rockefeller Family Trust, Inc.
The First Tee of Greater Houston
American Academy of Arts & Sciences
Credit Suisse AG
Massachusetts Institute of Technology
Zurich Chamber of Commerce
Sunoco Chemicals, Inc.
Institute International d'Etudes Bancaires
Sunoco Partners LLC
Lucerne Festival
International Institute for Management Development
Avenir Suisse
Swiss Finance Council
IMD Scholarship Foundation
Zurich Bar Association
Swiss Bankers Association
National Theatre of Scotland
New York State Bar Association
United Way of Greater Houston
European Financial Services Round Table
Company contact information
980 Great West road
TW8 9GS Brentford, Greater London
United Kingdom

Phone : +44 (0)20 8047 5000
Fax : +44 (0)20 8047 7807
Internet : http://www.gsk.com
Markets and indexes
- London Stock Exchange, SETS
- Main Market
- FTSE 100 / FTSE 350, FTSE All-Share, FTSE Eurotop 100, Low Carbon 100 Europe, Stoxx Europe 50, Stoxx Global 200, Stoxx UK 50
Stock Exchange Codes
- ISIN Code :  GB0009252882
- Bloomberg Code :  GSK:LN
- Reuters Code :  GSK.L
- Datastream Code :  GSK
© 2017 People , Fundamentals and Ownership    © 2017 Cofisem